|
1
|
Rosano C, Marsland AL and Gianaros PJ:
Maintaining brain health by monitoring inflammatory processes: A
mechanism to promote successful aging. Aging Dis. 3:16–33.
2012.PubMed/NCBI
|
|
2
|
Carter SF, Schöll M, Almkvist O, Wall A,
Engler H, Långström B and Nordberg A: Evidence for astrocytosis in
prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: A
multitracer PET paradigm combining 11C-Pittsburgh compound B and
18F-FDG. J Nucl Med. 53:37–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choo IL, Carter SF, Schöll ML and Nordberg
A: Astrocytosis measured by 11C-deprenyl PET correlates
with decrease in gray matter density in the parahippocampus of
prodromal Alzheimer's patients. Eur J Nucl Med Mol Imaging.
41:2120–2126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wharton SB, O'Callaghan JP, Savva GM,
Nicoll JA, Matthews F, Simpson JE, Forster G, Shaw PJ, Brayne C and
Ince PG: MRC Cognitive Function and Ageing Neuropathology Study
Group: Population variation in glial fibrillary acidic protein
levels in brain ageing: Relationship to Alzheimer-type pathology
and dementia. Dement Geriatr Cogn Disord. 27:465–473. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simpson JE, Ince PG, Lace G, Forster G,
Shaw PJ, Matthews F, Savva G, Brayne C and Wharton SB: MRC
Cognitive Function and Ageing Neuropathology Study Group: Astrocyte
phenotype in relation to Alzheimer-type pathology in the ageing
brain. Neurobiol Aging. 31:578–590. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Medeiros R and LaFerla FM: Astrocytes:
Conductors of the Alzheimer disease neuroinflammatory symphony. Exp
Neurol. 239:133–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mrak RE and Griffin WS: Interleukin-1,
neuroinflammation, and Alzheimer's disease. Neurobiol Aging.
22:903–908. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ghosh S, Wu MD, Shaftel SS, Kyrkanides S,
LaFerla FM, Olschowka JA and O'Banion MK: Sustained interleukin-1β
overexpression exacerbates tau pathology despite reduced amyloid
burden in an Alzheimer's mouse model. J Neurosci. 33:5053–5064.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Holmes C, Cunningham C, Zotova E,
Culliford D and Perry VH: Proinflammatory cytokines, sickness
behavior, and Alzheimer disease. Neurology. 77:212–218. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ho L, Purohit D, Haroutunian V, Luterman
JD, Willis F, Naslund J, Buxbaum JD, Mohs RC, Aisen PS and
Pasinetti GM: Neuronal cyclooxygenase 2 expression in the
hippocampal formation as a function of the clinical progression of
Alzheimer disease. Arch Neurol. 58:487–492. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mollace V, Colasanti M, Muscoli C, Lauro
GM, Iannone M, Rotiroti D and Nistico G: The effect of nitric oxide
on cytokine-induced release of PGE2 by human cultured astroglial
cells. Br J Pharmacol. 124:742–746. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Samy AS and Igwe OJ: Regulation of
IL-1β-induced cyclooxygenase-2 expression by interactions of Aβ
peptide, apolipoprotein E and nitric oxide in human neuroglioma. J
Mol Neurosci. 47:533–545. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ben Haim L, Carrillo-de Sauvage MA,
Ceyzériat K and Escartin C: Elusive roles for reactive astrocytes
in neurodegenerative diseases. Front Cell Neurosci. 9:2782015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Collino M, Aragno M, Mastrocola R,
Gallicchio M, Rosa AC, Dianzani C, Danni O, Thiemermann C and
Fantozzi R: Modulation of the oxidative stress and inflammatory
response by PPAR-gamma agonists in the hippocampus of rats exposed
to cerebral ischemia/reperfusion. Eur J Pharmacol. 530:70–80. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rinaldi P, Polidori MC, Metastasio A,
Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U
and Mecocci P: Plasma antioxidants are similarly depleted in mild
cognitive impairment and in Alzheimer's disease. Neurobiol Aging.
24:915–919. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Torres LL, Quaglio NB, de Souza GT, Garcia
RT, Dati LM, Moreira WL, Loureiro AP, de Souza-Talarico JN, Smid J,
Porto CS, et al: Peripheral oxidative stress biomarkers in mild
cognitive impairment and Alzheimer's disease. J Alzheimers Dis.
26:59–68. 2011.PubMed/NCBI
|
|
17
|
López N, Tormo C, De Blas I, Llinares I
and Alom J: Oxidative stress in Alzheimer's disease and mild
cognitive impairment with high sensitivity and specificity. J
Alzheimers Dis. 33:823–829. 2013.PubMed/NCBI
|
|
18
|
Yan MH, Wang X and Zhu X: Mitochondrial
defects and oxidative stress in Alzheimer disease and Parkinson
disease. Free Radic Biol Med. 62:90–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rocha NP, Teixeira AL, Scalzo PL, Barbosa
IG, de Sousa MS, Morato IB, Vieira EL, Christo PP, Palotás A and
Reis HJ: Plasma levels of soluble tumor necrosis factor receptors
are associated with cognitive performance in Parkinson's disease.
Mov Disord. 29:527–531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lindqvist D, Hall S, Surova Y, Nielsen HM,
Janelidze S, Brundin L and Hansson O: Cerebrospinal fluid
inflammatory markers in Parkinson's disease-associations with
depression, fatigue, and cognitive impairment. Brain Behav Immun.
33:183–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou XQ, Wu DW, Zhang CX, Yan R, Yang C,
Rong CP, Zhang L, Chang X, Su RY, Zhang SJ, et al: Bushen-Yizhi
formula ameliorates cognition deficits and attenuates oxidative
stressrelated neuronal apoptosis in scopolamine-induced senescence
in mice. Int J Mol Med. 34:429–439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hou XQ, Zhang L, Yang C, Rong CP, He WQ,
Zhang CX, Li S, Su RY, Chang X, Qin JH, et al: Alleviating effects
of Bushen-Yizhi formula on ibotenic acid-induced cholinergic
impairments in rat. Rejuvenation Res. 18:111–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Del Valle J, Bayod S, Camins A,
Beas-Zárate C, Velázquez-Zamora DA, González-Burgos I and Pallàs M:
Dendritic spine abnormalities in hippocampal CA1 pyramidal neurons
underlying memory deficits in the SAMP8 mouse model of Alzheimer's
disease. J Alzheimers Dis. 32:233–240. 2012.PubMed/NCBI
|
|
24
|
Chen Y, Wei G, Nie H, Lin Y, Tian H, Liu
Y, Yu X, Cheng S, Yan R, Wang Q, et al: β-Asarone prevents
autophagy and synaptic loss by reducing ROCK expression in
asenescence-accelerated prone 8 mice. Brain Res. 1552:41–54. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu L, Zhang L, Zhan L, Lu X, Peng J,
Liang L, Liu Y, Zheng L, Zhang F and Liu Q: The effects of Zibu
Piyin Recipe components on scopolamine-induced learning and memory
impairment in the mouse. J Ethnopharmacol. 151:576–582. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng XR, Zhou WX and Zhang YX: The
behavioral, pathological and therapeutic features of the
senescence-accelerated mouse prone 8 strain as an Alzheimer's
disease animal model. Ageing Res Rev. 13:13–37. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Orejana L, Barros-Miñones L, Jordán J,
Puerta E and Aguirre N: Sildenafil ameliorates cognitive deficits
and tau pathology in a senescence-accelerated mouse model.
Neurobiol Aging. 33:625.e11–e20. 2012. View Article : Google Scholar
|
|
29
|
He XL, Zhou WQ, Bi MG and Du GH:
Neuroprotective effects of icariin on memory impairment and
neurochemical deficits in senescence-accelerated mouse prone 8
(SAMP8) mice. Brain Res. 1334:73–83. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Engelhart MJ, Geerlings MI, Meijer J,
Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A,
Witteman JC and Breteler MM: Inflammatory proteins in plasma and
the risk of dementia: The rotterdam study. Arch Neurol. 61:668–672.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koyama A, O'Brien J, Weuve J, Blacker D,
Metti AL and Yaffe K: The role of peripheral inflammatory markers
in dementia and Alzheimer's disease: A meta-analysis. J Gerontol A
Biol Sci Med Sci. 68:433–440. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kashon ML, Ross GW, O'Callaghan JP, Miller
DB, Petrovitch H, Burchfiel CM, Sharp DS, Markesbery WR, Davis DG,
Hardman J, et al: Associations of cortical astrogliosis with
cognitive performance and dementia status. J Alzheimers Dis.
6(595–604): discussion 673–681. 2004.PubMed/NCBI
|
|
33
|
Watanabe K, Tonosaki K, Kawase T, Karasawa
N, Nagatsu I, Fujita M and Onozuka M: Evidence for involvement of
dysfunctional teeth in the senile process in the hippocampus of
SAMP8 mice. Exp Gerontol. 36:283–295. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fernandez-Gómez FJ, Muñoz-Delgado E,
Montenegro MF, Campoy FJ, Vidal CJ and Jordán J: Cholinesterase
activity in brain of senescence-accelerated-resistant mouse SAMR1
and its variation in brain of senescence-accelerated-prone mouse
SAMP8. J Neurosci Res. 88:155–166. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Furman JL, Sama DM, Gant JC, Beckett TL,
Murphy MP, Bachstetter AD, Van Eldik LJ and Norris CM: Targeting
astrocytes ameliorates neurologic changes in a mouse model of
Alzheimer's disease. J Neurosci. 32:16129–16140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Carrero I, Gonzalo MR, Martin B,
Sanz-Anquela JM, Arévalo-Serrano J and Gonzalo-Ruiz A: Oligomers of
β-amyloid protein (Aβ1-42) induce the activation of
cyclooxygenase-2 in astrocytes via an interaction with
interleukin-1β, tumour necrosis factor-α, and a nuclear factor κ-B
mechanism in the rat brain. Exp Neurol. 236:215–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Eriksson UK, Pedersen NL, Reynolds CA,
Hong MG, Prince JA, Gatz M, Dickman PW and Bennet AM: Associations
of gene sequence variation and serum levels of C-reactive protein
and interleukin-6 with Alzheimer's disease and dementia. J
Alzheimers Dis. 23:361–369. 2011.PubMed/NCBI
|
|
38
|
Liu J, Wang LN and Jia JP: Peroxisome
proliferator-activated receptor-gamma agonists for Alzheimer's
disease and amnestic mild cognitive impairment: A systematic review
and meta-analysis. Drugs Aging. 32:57–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pertusa M, Garcia-Matas S, Rodriguez-Farré
E, Sanfeliu C and Cristofol R: Astrocytes aged in vitro show a
decreased neuroprotective capacity. J Neurochem. 101:794–805. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Padurariu M, Ciobica A, Hritcu L, Stoica
B, Bild W and Stefanescu C: Changes of some oxidative stress
markers in the serum of patients with mild cognitive impairment and
Alzheimer's disease. Neurosci Lett. 469:6–10. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nakajima A, Aoyama Y, Nguyen TT, Shin EJ,
Kim HC, Yamada S, Nakai T, Nagai T, Yokosuka A, Mimaki Y, et al:
Nobiletin, a citrus flavonoid, ameliorates cognitive impairment,
oxidative burden, and hyperphosphorylation of tau in
senescence-accelerated mouse. Behav Brain Res. 250:351–360. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu JS, Lin TN and Wu KK: Rosiglitazone and
PPAR-gamma overexpression protect mitochondrial membrane potential
and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family
proteins. J Cell Physiol. 220:58–71. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cuesta S, Kireev R, Garcia C, Forman K,
Escames G, Vara E and Tresguerres JA: Beneficial effect of
melatonin treatment on inflammation, apoptosis and oxidative stress
on pancreas of a senescence accelerated mice model. Mech Ageing
Dev. 132:573–582. 2011. View Article : Google Scholar : PubMed/NCBI
|
